Department of Chemistry and Biochemistry, Jackson State University, 1400 Lynch St., Jackson, MS, 39217, USA.
Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, China.
Talanta. 2020 Sep 1;217:121106. doi: 10.1016/j.talanta.2020.121106. Epub 2020 May 1.
Clinical application of direct sampling electrospray ionization mass spectrometry (ESI-MS) remains limited due to problems associated with very "dirty" sample matrices. Herein we report on a microfluidic platform that allows direct mass spectrometric analysis of serum samples of microliter sizes. The platform integrates in-line paper adsorption-based sample clean-up and voltage assisted liquid desorption ESI-MS/MS (VAL DESI-MS/MS) to detect multiple targeted compounds of clinical interest. Adenosine monophosphate (AMP), adenosine diphosphate (ADP), and adenosine triphosphate (ATP) were selected as model analytes. Simultaneous quantification of these compounds in human serum samples was demonstrated. For all the three compounds, linear calibration curves were obtained in a concentration range from 0.20 to 20.0 μmol/L with r values ≥ 0.996. Limits of detection were 0.019, 0.015, and 0.011 μmol/L for AMP, ADP, and ATP, respectively. Recovery was found in the range from 96.5% to 103.5% at spiking concentrations of 0.25 and 2.50 μmol/L. The results indicate that the proposed microfluidic mass spectrometric platform is robust and effective. It may have a potential in clinical analysis.
直接采样电喷雾电离质谱(ESI-MS)的临床应用仍然受到与非常“脏”的样品基质相关的问题的限制。在此,我们报告了一种微流控平台,该平台允许对微升大小的血清样品进行直接质谱分析。该平台集成了在线纸吸附样品净化和电压辅助液体解吸 ESI-MS/MS(VAL DESI-MS/MS),以检测临床相关的多种靶向化合物。选择腺苷一磷酸(AMP)、腺苷二磷酸(ADP)和三磷酸腺苷(ATP)作为模型分析物。在人血清样品中证明了这些化合物的同时定量。对于所有三种化合物,在 0.20 至 20.0 μmol/L 的浓度范围内均获得线性校准曲线,r 值≥0.996。AMP、ADP 和 ATP 的检测限分别为 0.019、0.015 和 0.011 μmol/L。在 0.25 和 2.50 μmol/L 的加标浓度下,回收率在 96.5%至 103.5%之间。结果表明,所提出的微流控质谱平台稳健有效。它可能在临床分析中有应用潜力。